These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6478732)

  • 1. Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension.
    Lopez LM; Mehta JL; Baz R; Aguila E
    Clin Pharmacol Ther; 1984 Oct; 36(4):444-50. PubMed ID: 6478732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.
    Leenen FH; Burns RJ; Myers MG; Frankel D
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):499-504. PubMed ID: 1981020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic nitrendipine on casual (office) and 24-hour ambulatory blood pressure.
    White WB; Smith VE; McCabe EJ; Meeran MK
    Clin Pharmacol Ther; 1985 Jul; 38(1):60-4. PubMed ID: 3159531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered pressor responses in long-term nitrendipine treatment.
    Simon G; Snyder DK
    Clin Pharmacol Ther; 1984 Sep; 36(3):315-9. PubMed ID: 6380880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and cardiovascular effects of nitrendipine: a controlled study vs. placebo.
    Ferrara LA; Fasano ML; de Simone G; Soro S; Gagliardi R
    Clin Pharmacol Ther; 1985 Oct; 38(4):434-8. PubMed ID: 2931232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients.
    el-Beheiry H; Ruedy N; Wall RA; Murphy M; Wright JM
    Can J Cardiol; 1993; 9(1):41-6. PubMed ID: 8439828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy.
    Myers MG; Leenen FH; Burns R; Frankel D
    Clin Pharmacol Ther; 1986 Apr; 39(4):409-13. PubMed ID: 2869849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrendipine vs. long-acting nifedipine in mild, moderate and severe hypertension.
    Guazzi MD; De Cesare N; Galli C; Tamborini G; Salvioni A
    Angiology; 1986 Jul; 37(7):508-18. PubMed ID: 2942062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
    Johnson BF; Romero L; Marwaha R
    Clin Pharmacol Ther; 1986 Apr; 39(4):389-94. PubMed ID: 2937598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
    Byyny RL; Nies AS; LoVerde ME; Mitchell WD
    Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
    Knorr A; Stoepel K
    Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomized cross-over study of the efficacy and tolerability of nifedipine and nitrendipine in the treatment of mild to moderate hypertension.
    Heagerty AM; Swales JD
    Br J Clin Pharmacol; 1989 Apr; 27(4):411-6. PubMed ID: 2655687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
    Luft FC; Aronoff GR; Sloan RS; Fineberg NS; Weinberger MH
    Hypertension; 1985; 7(3 Pt 1):438-42. PubMed ID: 3158605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A; Lasaridis A; Settas L
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.
    Br J Clin Pharmacol; 1986 Jun; 21(6):621-6. PubMed ID: 2874821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.